Abstract

BackgroundNIS793 is a human IgG2 monoclonal antibody that binds to transforming growth factor beta (TGF-β). This first-in-human study investigated NIS793 plus spartalizumab treatment in patients with advanced solid tumors.MethodsPatients received...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Phase Ib study of the anti-TGF-β monoclonal antibody (mAb) NIS793 combined with spartalizumab (PDR001), a PD-1 inhibitor, in patients (pts) with advanced solid tumors.
Todd Michael Bauer ... Ignacio Garrido-Laguna
Journal of Clinical Oncology | VOL. 39
Todd Michael Bauer, et. al.Todd Michael Bauer ... Ignacio Garrido-Laguna
20 May 2021
523 Preliminary clinical experience with XmAb20717, a PD-1 x CTLA-4 bispecific antibody, in patients with advanced solid tumors
Elaine Shum ... Barbara Hickingbottom
Journal for ImmunoTherapy of Cancer | VOL. 9
Elaine Shum, et. al.Elaine Shum ... Barbara Hickingbottom
01 Nov 2021
A phase Ia/Ib, dose-escalation/expansion study of BI 907828 in combination with BI 754091 and BI 754111 in patients (pts) with advanced solid tumors.
Anthony W Tolcher ... Mrinal M Gounder
Journal of Clinical Oncology | VOL. 38
Anthony W Tolcher, et. al.Anthony W Tolcher ... Mrinal M Gounder
20 May 2020
A first-in-human, phase 1/2 trial of FOG-001, a β-catenin:TCF antagonist, in patients with locally advanced or metastatic solid tumors.
Kyriakos P Papadopoulos ... Samuel J Klempner
Journal of Clinical Oncology | VOL. 42
Kyriakos P Papadopoulos, et. al.Kyriakos P Papadopoulos ... Samuel J Klempner
01 Jun 2024
View more papers

More From: Journal for ImmunoTherapy of Cancer

Paper Title
Journal
Date
Author
Assessing the implications of sentinel lymph node removal in cervical cancer: an immunogenetic perspective – a SENTICOL ancillary study
Gaurav Thareja ... Alejandra Martinez
Journal for ImmunoTherapy of Cancer | VOL. 12
Gaurav Thareja, et. al.Gaurav Thareja ... Alejandra Martinez
15 Jul 2024
Novel insights into paclitaxel’s role on tumor-associated macrophages in enhancing PD-1 blockade in breast cancer treatment
Yoonjeong Choi ... In-San Kim
Journal for ImmunoTherapy of Cancer | VOL. 12
Yoonjeong Choi, et. al.Yoonjeong Choi ... In-San Kim
15 Jul 2024
Cantharidin overcomes IL-2Rα signaling-mediated vorinostat resistance in cutaneous T-cell lymphoma through reactive oxygen species
Man Zhu ... Yanmin Zhang
Journal for ImmunoTherapy of Cancer | VOL. 12
Man Zhu, et. al.Man Zhu ... Yanmin Zhang
14 Jul 2024
A crisis in clinical research
David S Hong ... Mario Sznol
Journal for ImmunoTherapy of Cancer | VOL. 12
David S Hong, et. al.David S Hong ... Mario Sznol
11 Jul 2024
View more papers